| [1] |
Maxmen A. Translational research: the American way[J].Nature,2011,478(7368):S16-18.
|
| [2] |
Translational research and experimental medicine in 2012[J].Lancet,2012,379(9810):1.
|
| [3] |
Ledford H.Translational research:4 ways to fix the clinical trial[J].Nature,2011,477(7366):526-528.
|
| [4] |
Blumberg RS,Dittel B,Hafler D,et al.Unraveling the autoimmune translational research process layer by layer[J].Nat Med,2012,18(1):35-41.
|
| [5] |
Fishburn CS.Translational research:the changing landscape of drug discovery[J].Drug Discov Today,2013,18(9/10):487-494.
|
| [6] |
Hobin JA,Galbraith RA.Engaging basic scientists in translational research[J].FASEB J,2012,26(6):2227-2230.
|
| [7] |
Wang C,Allegaert K,Peeters MY,et al.The allometric exponent for scaling clearance varies with age:a study on seven propofol datasets ranging from preterm neonates to adults[J].Br J Clin Pharmacol,2014,77(1):149-159.
|
| [8] |
Enbaum H,Ronfeld R.Interspecies pharmacokinetic scaling and the Dedrick plots[J].Am J Physiol,1983,245(6):R768-775.
|
| [9] |
Thompson AM. Translational research: a UK tissue bank for breast tumours[J].Nature,2012,485(7397):174-177.
|
| [10] |
Hennessy S,Flockhart DA.The need for translational research on drug-drug interactions[J].Clin Pharmacol Ther,2012,91(5):771-773.
|
| [11] |
Kahn JD.Connecting the dots in translational research[J].Nat Rev Drug Discov,2012,11(10):811-812.
|
| [12] |
Fontana JM,Alexander E,Salvatore M.Translational research in infectious disease:current paradigms and challenges ahead[J].Transl Res,2012,159(6):430-453.
|
| [13] |
Gill KL,Gertz M,Houston JB,et al.Application of a physiologically-based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation;utility of in vitro and in vivo data[J].Drug Metab Dispos,2013,41(4):744-753.
|
| [14] |
Suenderhauf C,Parrott N.A physiologically based pharmacokinetic model of the minipig:data compilation and model implementation[J].Pharm Res,2013,30(1):1-15.
|
| [15] |
Chudasama VL,Schaedeli Stark F,Harrold JM,et al.Semi-mechanistic population pharmacokinetic model of multivalent trastuzumab emtansine in patients with metastatic breast cancer[J].Clin Pharmacol Ther,2012,92(4):520-527.
|
| [16] |
Mager DE,Mody V,Xu C,et al.Physiologically based pharmacokinetic model for composite nanodevices:effect of charge and size on in vivo disposition[J].Pharm Res,2012,29(9):2534-2542.
|
| [17] |
Gandhi YA,Morris ME.Reevaluation of a quantitative structure pharmacokinetic model for biliary excretion in rats[J].Drug Metab Dispos,2012,40(7):1259-1262.
|
| [18] |
An G,Morris ME.A physiologically based pharmacokinetic model of mitoxantrone in mice and scale-up to humans:a semi-mechanistic model incorporating DNA and protein binding[J].AAPS J,2012,14(2):352-364.
|
| [19] |
Peters SA.Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis[J].Clin Pharmacokinet,2008,47(4):261-275.
|
| [20] |
Malmborg J,Ploeger BA.Predicting human exposure of active drug after oral prodrug administration,using a joined in vitro/in silico-in vivo extrapolation and physiologically-based pharmacokinetic modeling approach[J].J Pharmacol Toxicol Methods,2013,67(3):203-213.
|
| [21] |
Bungay PJ,Tweedy S,Howe DC,et al.Preclinical and clinical pharmacokinetics of pf-02413873,a nonsteroidal progesterone receptor antagonist[J].Drug Metab Dispos,2011,39(8):1396-1405.
|
| [22] |
Ait-Oudhia S,Scherrmann JM,Krzyzanski W.Simultaneous pharmacokinetics/pharmacodynamics modeling of recombinant human erythropoietin upon multiple intravenous dosing in rats[J].J Pharmacol Exp Ther,2010,334(3):897-910.
|
| [23] |
Jones HM,Barton HA,Lai Y,et al.Mechanistic pharmacokinetic modeling for the prediction of transportermediated disposition in humans from sandwich culture human hepatocyte data[J].Drug Metab Dispos,2012,40(5):1007-1017.
|
| [24] |
Albanese RA,Banks HT,Evans MV,et al.Physiologically based pharmacokinetic models for the transport of trichloroethylene in adipose tissue[J].Bull Math Biol,2002,64(1):97-131.
|
| [25] |
Poulin P,Haddad S.Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method[J].J Pharm Sci,2012,101(6):2250-2261.
|
| [26] |
Van Hasselt JG,Green B,Morrish GA.Leveraging physiological data from literature into a pharmacokinetic model to support informative clinical study design in pregnant women[J].Pharm Res,2012,29(6):1609-1617.
|
| [27] |
De Winter BC,Monchaud C,Prémaud A,et al.Bayesian estimation of mycophenolate mofetil in lung transplantation,using a population pharmacokinetic model developed in kidney and lung transplant recipients[J].Clin Pharmacokinet,2012,51(1):29-39.
|
| [28] |
Stevens J, Ploeger BA, van der Graaf PH, et al. Systemic and direct nose-to-brain transport pharmacokinetic model for remoxipride after intravenous and intranasal administration[J].Drug Metab Dispos,2011,39(12):2275-2282.
|
| [29] |
Van den Broek MP,Huitema AD,van Hasselt JG,et al.Lidocaine(lignocaine)dosing regimen based upon a population pharmacokinetic model for preterm and term neonates with seizures[J].Clin Pharmacokinet,2011,50(7):461-469.
|
| [30] |
Gao G, Law FC. Physiologically based pharmacokinetics of matrine in the rat after oral administration of pure chemical and acapha[J].Drug Metab Dispos,2009,37(4):884-891.
|
| [31] |
Brantley SJ,Gufford BT,Dua R,et al.Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction[J].CPT Pharmacometrics Syst Pharmacol,2014,3:e107.
|
| [32] |
Hao K,Qi Q,Wan P,et al.Prediction of human pharmacokinetics from preclinical information of rhein,an antidiabetic nephropathy drug,using a physiologically based pharmacokinetic model[J].Basic Clin Pharmacol Toxicol,2014,114(2):160-167.
|
本站查看
下载:
